Quick Answer
Genenta Science S.p.A. reported Operating Income of -$9.76 million for fiscal year 2024.
Genenta Science S.p.A. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$9.76M | +16.8% |
| 2023 | -$11.73M | -6.2% |
| 2022 | -$11.04M | -94.2% |
| 2021 | -$5.69M | -1.7% |
| 2020 | -$5.59M | -20.9% |
| 2019 | -$4.62M | — |
- Genenta Science S.p.A. showed an increase of +16.8% in Operating Income compared to the prior fiscal year.
- Over the 2019–2024 period, Genenta Science S.p.A.’s operating income has declined by 111.1% (from -$4.62 million to -$9.76 million).
- The most recent figure is from Genenta Science S.p.A.’s fiscal year 2024 report (Form 20-F), filed with the SEC on March 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: